Aspirin Can Cut Risk of Some Breast Cancer: Study
 (Chicago, Reuters Health, 5/25/04)

Scientists report that some pain-relievers may decrease the risk of developing estrogen-related breast cancer. Study participants who had taken non-steroidal anti-inflammatory drugs (NSAIDs), such as aspirin, a minimum of once a week for at least six months had significantly lower breast cancer rates. These findings suggest that aspirin and NSAIDs may be chemopreventive agents against breast cancer; however, their possible benefits must be weighed against such side-effects as peptic ulcers and gastrointestinal bleeding.